WAIVER AND FIRST AMENDMENT TO credit agreement and guarantyBioXcel Therapeutics, Inc. • November 14th, 2023 • Pharmaceutical preparations
Company FiledNovember 14th, 2023 IndustryThis Waiver and First Amendment to Credit Agreement and Guaranty (this “Amendment”) is made as of November 13, 2023, by and among BIOXCEL THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the lenders party hereto (collectively, the “Lenders” and individually, a “Lender”) and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent on behalf of the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).